801 related articles for article (PubMed ID: 7642212)
1. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C
Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
3. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
Luo HY; Hofstetter H; Banchereau J; Delespesse G
J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
[TBL] [Abstract][Full Text] [Related]
5. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
6. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
7. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
Hamano T; Asofsky R
J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
Santos-Argumedo L; Gordon J; Heath AW; Howard M
Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
[TBL] [Abstract][Full Text] [Related]
9. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.
van Lier RA; Brouwer M; Rebel VI; van Noesel CJ; Aarden LA
Immunology; 1989 Sep; 68(1):45-50. PubMed ID: 2530156
[TBL] [Abstract][Full Text] [Related]
10. Antigen-dependent regulation of IgE antibody production by human antigen-specific B cells.
Oshiba A; Gelfand EW
J Immunol; 1996 Dec; 157(11):4870-5. PubMed ID: 8943390
[TBL] [Abstract][Full Text] [Related]
11. A novel pathway of human B cell activation initiated by CK226 surface antigen.
Poggi A; Maggi E; Biagiotti R; Giudizi MG; Almerigogna F; Pella N; Caligaris-Cappio F; Romagnani S; Moretta L
Eur J Immunol; 1990 May; 20(5):1161-5. PubMed ID: 2141569
[TBL] [Abstract][Full Text] [Related]
12. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
13. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
Hamano T; Leiserson WM; Asofsky R
J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
[TBL] [Abstract][Full Text] [Related]
14. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
Phillips NE; Parker DC
J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
[TBL] [Abstract][Full Text] [Related]
16. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
King CA; Wills MR; Hamblin TJ; Stevenson FK
Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
18. Frequency of human B cells that differentiate in response to anti-CD3-activated T cells.
Amoroso K; Lipsky PE
J Immunol; 1990 Nov; 145(10):3155-61. PubMed ID: 2146316
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
Suzuki T; Cooper MD
J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
[TBL] [Abstract][Full Text] [Related]
20. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
